全文获取类型
收费全文 | 895065篇 |
免费 | 74428篇 |
国内免费 | 1974篇 |
专业分类
耳鼻咽喉 | 13372篇 |
儿科学 | 25660篇 |
妇产科学 | 25787篇 |
基础医学 | 128354篇 |
口腔科学 | 25999篇 |
临床医学 | 79011篇 |
内科学 | 170732篇 |
皮肤病学 | 17411篇 |
神经病学 | 73348篇 |
特种医学 | 36624篇 |
外国民族医学 | 171篇 |
外科学 | 142260篇 |
综合类 | 25343篇 |
现状与发展 | 2篇 |
一般理论 | 302篇 |
预防医学 | 69545篇 |
眼科学 | 20983篇 |
药学 | 67346篇 |
中国医学 | 1625篇 |
肿瘤学 | 47592篇 |
出版年
2018年 | 8488篇 |
2015年 | 8811篇 |
2014年 | 12554篇 |
2013年 | 18692篇 |
2012年 | 25870篇 |
2011年 | 27052篇 |
2010年 | 15668篇 |
2009年 | 14708篇 |
2008年 | 25268篇 |
2007年 | 27372篇 |
2006年 | 27168篇 |
2005年 | 26840篇 |
2004年 | 26031篇 |
2003年 | 25047篇 |
2002年 | 23961篇 |
2001年 | 36103篇 |
2000年 | 36586篇 |
1999年 | 30948篇 |
1998年 | 9050篇 |
1997年 | 8210篇 |
1996年 | 8056篇 |
1995年 | 8225篇 |
1994年 | 7897篇 |
1992年 | 26815篇 |
1991年 | 26267篇 |
1990年 | 25744篇 |
1989年 | 24794篇 |
1988年 | 23338篇 |
1987年 | 22975篇 |
1986年 | 21830篇 |
1985年 | 21184篇 |
1984年 | 16465篇 |
1983年 | 14045篇 |
1982年 | 8949篇 |
1981年 | 8282篇 |
1980年 | 7715篇 |
1979年 | 16755篇 |
1978年 | 12133篇 |
1977年 | 10200篇 |
1976年 | 9345篇 |
1975年 | 10150篇 |
1974年 | 12644篇 |
1973年 | 12162篇 |
1972年 | 11551篇 |
1971年 | 10689篇 |
1970年 | 10219篇 |
1969年 | 9914篇 |
1968年 | 8911篇 |
1967年 | 8239篇 |
1966年 | 7655篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
51.
52.
53.
54.
Milan Milojevic Patrick W. Serruys Joseph F. Sabik David E. Kandzari Erick Schampaert Ad J. van Boven Ferenc Horkay Imre Ungi Samer Mansour Adrian P. Banning David P. Taggart Manel Sabaté Anthony H. Gershlick Andrzej Bochenek Jose Pomar Nicholas J. Lembo Nicolas Noiseux John D. Puskas Arie Pieter Kappetein 《Journal of the American College of Cardiology》2019,73(13):1616-1628
Background
The randomized EXCEL (Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial reported a similar rate of the 3-year composite primary endpoint of death, myocardial infarction (MI), or stroke in patients with left main coronary artery disease (LMCAD) and site-assessed low or intermediate SYNTAX scores treated with percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). Whether these results are consistent in high-risk patients with diabetes, who have fared relatively better with CABG in most prior trials, is unknown.Objectives
In this pre-specified subgroup analysis from the EXCEL trial, the authors sought to examine the effect of diabetes in patients with LMCAD treated with PCI versus CABG.Methods
Patients (N = 1,905) with LMCAD and site-assessed low or intermediate CAD complexity (SYNTAX scores ≤32) were randomized 1:1 to PCI with everolimus-eluting stents versus CABG, stratified by the presence of diabetes. The primary endpoint was the rate of a composite of all-cause death, stroke, or MI at 3 years. Outcomes were examined in patients with (n = 554) and without (n = 1,350) diabetes.Results
The 3-year composite primary endpoint was significantly higher in diabetic compared with nondiabetic patients (20.0% vs. 12.9%; p < 0.001). The rate of the 3-year primary endpoint was similar after treatment with PCI and CABG in diabetic patients (20.7% vs. 19.3%, respectively; hazard ratio: 1.03; 95% confidence interval: 0.71 to 1.50; p = 0.87) and nondiabetic patients (12.9% vs. 12.9%, respectively; hazard ratio: 0.98; 95% confidence interval: 0.73 to 1.32; p = 0.89). All-cause death at 3 years occurred in 13.6% of PCI and 9.0% of CABG patients (p = 0.046), although no significant interaction was present between diabetes status and treatment for all-cause death (p = 0.22) or other endpoints, including the 3-year primary endpoint (p = 0.82) or the major secondary endpoints of death, MI, or stroke at 30 days (p = 0.61) or death, MI, stroke, or ischemia-driven revascularization at 3 years (p = 0.65).Conclusions
In the EXCEL trial, the relative 30-day and 3-year outcomes of PCI with everolimus-eluting stents versus CABG were consistent in diabetic and nondiabetic patients with LMCAD and site-assessed low or intermediate SYNTAX scores.(Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization [EXCEL]; NCT01205776) 相似文献55.
56.
57.
Ada Gillissen Thomas van den Akker Camila Caram-Deelder Dacia D. C. A. Henriquez Kitty W. M. Bloemenkamp Jeroen Eikenboom 《Scandinavian journal of clinical and laboratory investigation》2019,79(1-2):32-38
Haemostatic treatment in women experiencing postpartum haemorrhage is increasingly based on point-of-care devices such as ROTEM® thromboelastometry. Recently, a fully automated successor of the ROTEM® Delta device, the ROTEM® Sigma was introduced. To determine whether these devices provide similar results, we compared ROTEM® parameters using the ROTEM® Delta and Sigma devices in women experiencing postpartum haemorrhage. Prospective observational cohort study of 23 women experiencing postpartum haemorrhage. ROTEM® INTEM, EXTEM, FIBTEM and APTEM measurements handled by the ROTEM® Delta and Sigma devices were compared. ROTEM® FIBTEM values were also related to Clauss fibrinogen values. A correlation of Spearman’s r (rs) varying between 0.76 and 0.95 was displayed between clot firmness measured in millimeters at 5 (A5), 10 (A10) and 20 (A20) minutes after start of clot formation measured by EXTEM, INTEM and APTEM assays executed on both devices; A5, A10 and A20 of FIBTEM correlated less well (rS between 0.71 and 0.74), especially after five and ten minutes. Correlation between both devices regarding clotting time (CT) was poor. The observed correlation between levels of Clauss fibrinogen and FIBTEM A5 was rs = 0.70, (95% confidence interval (CI): 0.38 to 0.87) for Delta and rs = 0.85, (CI 0.65 to 0.94) for Sigma. A5, A10 and A20 measured in EXTEM, INTEM and APTEM obtained from ROTEM® Delta and Sigma devices were similar. EXTEM, FIBTEM and APTEM CT values from both devices showed no correlation. Substantial variation was found between FIBTEM assays of the devices. Consequently, results of FIBTEM assays should always be interpreted in the context of device-specific reference values. Correlation with Clauss fibrinogen was better in the ROTEM® Sigma device. 相似文献
58.
Amine Riahi Claude Kauffmann Eric Therasse Florence Morin-Roy Stephane Elkouri Patrick Gilbert Marie-France Giroux Pierre Perreault Louis Bouchard Vincent L. Oliva Gilles Soulez 《Journal of vascular and interventional radiology : JVIR》2019,30(4):523-530
Purpose
To compare automated measurements of maximal diameter (Dmax) of abdominal aortic aneurysm (AAA) orthogonal to luminal or outer wall envelope centerline for endovascular repair (EVAR) follow-up.Material and Methods
Eighty-three consecutive patients with AAA treated by EVAR who had at least 1 computed tomography (CT) scan before and 2 CT scans after EVAR with at least 5 months’ interval were included. Three-dimensional reconstruction of the AAA was achieved with dedicated segmentation software. Performances of automated calculation algorithms of Dmax perpendicular to lumen or outer wall envelope centerlines were then compared to manual measurement of Dmax on double-oblique multiplanar reconstruction (gold standard). Accuracy of automated Dmax measurements at baseline, follow-up, and progression over time was evaluated by calculation of mean error, Bland-Altman plot, and regression models.Results
Disagreement in Dmax measurements between outer wall envelope algorithm and manual method was insignificant (mean error: baseline, -0.07 ± 1.66 mm, P = .7; first follow-up, 0.24 ± 1.69 mm, P = .2; last follow-up, -0.41 ± 2.74 mm, P = .17); whereas significant discrepancies were found between the luminal algorithm and the manual method (mean error: baseline, -1.24 ± 2.01 mm, P < .01; first follow-up, -1.49 ± 3.30 mm, P < .01; last follow-up, -1.78 ± 3.60 mm, P < .01). Dmax progression results were more accurate with AAA outer wall envelope algorithm compared to luminal method (P = .2).Conclusions
AAA outer wall envelope segmentation is recommended to enable automated calculation of Dmax perpendicular to its centerline during EVAR follow-up. 相似文献59.
60.